TNFSF10 and ovarian carcinoma: These data indicate that: ovarian cancer cell lines are sensitive to LBW242 effects, particularly in combined treatment with TRAIL; LBW242 exerts a synergistic or additive anti-tumor activity with TRAIL in ovarian cancer cell lines.